These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37373011)

  • 1. Synthesis and Anticancer Activity of A-Ring-Modified Derivatives of Dihydrobetulin.
    Tolmacheva I; Beloglazova Y; Nazarov M; Gagarskikh O; Grishko V
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
    Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triterpenoids with modified A-ring as modulators of P-gp-dependent drug-resistance in cancer cells.
    Rybalkina EY; Moiseeva NI; Karamysheva AF; Eroshenko DV; Konysheva AV; Nazarov AV; Grishko VV
    Chem Biol Interact; 2021 Oct; 348():109645. PubMed ID: 34516973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnosine Potentiates Doxorubicin-Induced Cytotoxicity in Resistant NCI/ADR-RES Cells by Inhibiting P-Glycoprotein-In Silico and In Vitro Evidence.
    Morsy MA; Kandeel M; Ibrahim ARN; Abdel-Gaber SA; Jacob S; Venugopala KN; Shinu P; El-Daly M
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
    Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS
    Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zhankuic Acids A, B and C from
    Teng YN; Wang YH; Wu TS; Hung HY; Hung CC
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766413
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of P-glycoprotein-mediated multidrug resistance by natural N-alkylated indole alkaloid derivatives in KB-ChR-8-5 drug-resistant cancer cells.
    Bharathiraja P; Cardoso DSP; Rajendra Prasad N; Mulhovo S; Lakra DS; Ferreira MU
    J Biochem Mol Toxicol; 2023 Sep; 37(9):e23421. PubMed ID: 37345739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites.
    Teng YN; Huang BH; Huang SY; Wu IT; Wu TS; Lee TE; Hung CC
    Biomed Pharmacother; 2021 Dec; 144():112379. PubMed ID: 34794239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
    Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, in silico and in vitro studies of new 1,4-dihydropiridine derivatives for antitumor and P-glycoprotein inhibitory activity.
    Mollazadeh S; Sahebkar A; Kalalinia F; Behravan J; Hadizadeh F
    Bioorg Chem; 2019 Oct; 91():103156. PubMed ID: 31416030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin.
    Jovelet C; Bénard J; Forestier F; Farinotti R; Bidart JM; Gil S
    Eur J Pharm Sci; 2012 Aug; 46(5):484-91. PubMed ID: 22484209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase Cα protects against multidrug resistance in human colon cancer cells.
    Lee SK; Shehzad A; Jung JC; Sonn JK; Lee JT; Park JW; Lee YS
    Mol Cells; 2012 Jul; 34(1):61-9. PubMed ID: 22639047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency.
    Lin R; Zhang L; Ye B; Wang Y; Li YD; Jason H; Liu W; Hu P; Chen J; Chen ZS; Chen Z
    Cancer Lett; 2023 Jun; 563():216181. PubMed ID: 37086953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells.
    Bai Z; Liu X; Guan Q; Ding N; Wei Q; Tong B; Zhao M; Zhang W; Ma L
    Chem Biol Interact; 2020 Jan; 315():108886. PubMed ID: 31682804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.
    Dai CL; Liang YJ; Chen LM; Zhang X; Deng WJ; Su XD; Shi Z; Wu CP; Ashby CR; Akiyama S; Ambudkar SV; Chen ZS; Fu LW
    Biochem Pharmacol; 2009 Aug; 78(4):355-64. PubMed ID: 19410561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells.
    Abdelfatah S; Böckers M; Asensio M; Kadioglu O; Klinger A; Fleischer E; Efferth T
    Phytomedicine; 2021 Jun; 86():153196. PubMed ID: 32229058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of cucurbitacin E from Citrullus colocynthis against multidrug-resistant cancer cells.
    Saeed MEM; Boulos JC; Elhaboub G; Rigano D; Saab A; Loizzo MR; Hassan LEA; Sugimoto Y; Piacente S; Tundis R; Yagi S; Khalid H; Efferth T
    Phytomedicine; 2019 Sep; 62():152945. PubMed ID: 31132750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.